Menu
Back to User profile » Dr Marc Miravitlles
Papers published by Dr Marc Miravitlles:
Clinical Concepts for Triple Therapy Use in Patients with COPD: A Delphi Consensus
Miravitlles M, Acharya S, Aggarwal B, Fernandes FL, Dreyse J, Jardim JR, Juthong S, Levy G, Sivori M
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1853-1866
Published Date: 28 August 2023
Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin
Torres-Durán M, López-Campos JL, Calle Rubio M, Montero-Martínez C, Priegue Carrera A, Amaro Rodríguez R, Barrecheguren M, Barrio Guirado MA, Callejas-González FJ, Casas-Maldonado F, Diab-Cáceres L, García-Meseguer P, Hernández-Pérez JM, Lázaro-Asegurado L, Martínez-González C, Martínez Rivera C, Michel FJ, Montoro-Ronsano JB, Sánchez R, Ortiz-Pica M, Parra I, Quintero García JP, Ruiz-Serrano-de la Espada MDR, Tortajada-Goitia B, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1691-1700
Published Date: 4 August 2023
Discriminant Validity of a Single Clinical Question for the Screening of Inactivity in Individuals Living with COPD
Ramon MA, Esteban C, Ortega F, Cebollero P, Carrascosa I, Martinez-González C, Sobradillo P, Soler-Cataluña JJ, Miravitlles M, García-Río F
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:3033-3044
Published Date: 2 December 2022
Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy
Chen S, Miravitlles M, Rhee CK, Pavord ID, Jones R, Carter V, Emmanuel B, Alacqua M, Price DB
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2187-2200
Published Date: 9 September 2022
Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey
Miravitlles M, González-Torralba F, Represas-Represas C, Pomares X, Márquez-Martín E, González C, Amado C, Forné C, Alonso S, Alcázar B, Barrecheguren M, Jurado Mirete JM, Naval E
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1577-1587
Published Date: 12 July 2022
Diaphragmatic Movement at Rest and After Exertion: A Non-Invasive and Easy to Obtain Prognostic Marker in COPD
Mekov E, Yanev N, Kurtelova N, Mihalova T, Tsakova A, Yamakova Y, Miravitlles M, Petkov R
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1041-1050
Published Date: 5 May 2022
The Impact of Chronic Bronchial Infection in COPD: A Proposal for Management
Martinez-Garcia MA, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:621-630
Published Date: 23 March 2022
A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid
Miravitlles M, Verhamme K, Calverley PMA, Dreher M, Bayer V, Gardev A, de la Hoz A, Wedzicha J, Price D
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:545-558
Published Date: 11 March 2022
CONQUEST: A Quality Improvement Program for Defining and Optimizing Standards of Care for Modifiable High-Risk COPD Patients
Alves L, Pullen R, Hurst JR, Miravitlles M, Carter V, Chen R, Couper A, Dransfield M, Evans A, Hardjojo A, Jones D, Jones R, Kerr M, Kostikas K, Marshall J, Martinez F, Melle MV, Murray R, Muro S, Nordon C, Pollack M, Price C, Sharma A, Singh D, Winders T, Price DB
Patient Related Outcome Measures 2022, 13:53-68
Published Date: 23 February 2022
Long-Term Risk of Mortality Associated with Isolation of Pseudomonas aeruginosa in COPD: A Systematic Review and Meta-Analysis
Martinez-García MA, Rigau D, Barrecheguren M, García-Ortega A, Nuñez A, Oscullo Yepez G, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:371-382
Published Date: 16 February 2022
Inhaled Corticosteroid Use Among COPD Patients in Primary Care in Spain
Miravitlles M, Roman-Rodríguez M, Ribera X, Ritz J, Izquierdo JL
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:245-258
Published Date: 25 January 2022
Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group
Greulich T, Albert A, Cassel W, Boeselt T, Peychev E, Klemmer A, Ferreira F, Clarenbach C, Torres-Duran ML, Turner AM, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:53-64
Published Date: 5 January 2022
Economic Impact of Low Adherence to COPD Management Guidelines in Spain
Miravitlles M, Solé A, Aguilar H, Ampudia A, Costa-Samarra J, Mallén-Alberdi M, Nieves D
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:3131-3143
Published Date: 16 November 2021
Estimated Prevalence and Number of PiMZ Genotypes of Alpha-1 Antitrypsin in Seventy-Four Countries Worldwide
Martinez-González C, Blanco I, Diego I, Bueno P, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2617-2630
Published Date: 17 September 2021
CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care
Pullen R, Miravitlles M, Sharma A, Singh D, Martinez F, Hurst JR, Alves L, Dransfield M, Chen R, Muro S, Winders T, Blango C, Muellerova H, Trudo F, Dorinsky P, Alacqua M, Morris T, Carter V, Couper A, Jones R, Kostikas K, Murray R, Price DB
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2301-2322
Published Date: 12 August 2021
Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain
Alcázar-Navarrete B, García-Rio F, Sánchez G, Mariscal E, García A, Cuesta M, Uría E, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2149-2161
Published Date: 21 July 2021
Update on Asthma–COPD Overlap (ACO): A Narrative Review
Mekov E, Nuñez A, Sin DD, Ichinose M, Rhee CK, Maselli DJ, Coté A, Suppli Ulrik C, Maltais F, Anzueto A, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1783-1799
Published Date: 17 June 2021
Relationship Between Clinical Control, Respiratory Symptoms and Quality of Life for Patients with COPD
Alcazar-Navarrete B, Fuster A, García Sidro P, García Rivero JL, Abascal-Bolado B, Pallarés-Sanmartín A, Márquez E, Valido-Morales A, Boldova Loscertales A, Callejas-Gonzalez FJ, Palop M, Riesco JA, Golpe R, Soler-Cataluña JJ, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2683-2693
Published Date: 28 October 2020
The Experience of COPD Patients in Lockdown Due to the COVID-19 Pandemic
Pleguezuelos E, Del Carmen A, Moreno E, Ortega P, Vila X, Ovejero L, Serra-Prat M, Palomera E, Garnacho-Castaño MV, Loeb E, Farago G, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2621-2627
Published Date: 23 October 2020
Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory
Belmonte I, Nuñez A, Barrecheguren M, Esquinas C, Pons M, López-Martínez RM, Ruiz G, Blanco-Grau A, Ferrer R, Genescà J, Miravitlles M, Rodríguez-Frías F
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2421-2431
Published Date: 7 October 2020
A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future
Pérez de Llano L, Miravitlles M, Golpe R, Alvarez-Gutiérrez FJ, Cisneros C, Almonacid C, Martinez-Moragon E, Gonzalez-Barcala FJ, Ramos-Barbón D, Plaza V, Lopez-Campos JL, de-Torres JP, Casanova C, Garcia Rivero JL, Rodriguez Hermosa J, Calle Rubio M, Soler-Cataluña JJ, Cosio BG
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2091-2100
Published Date: 4 September 2020
Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD
Miravitlles M, Marín A, Huerta A, Carcedo D, Villacampa A, Puig-Junoy J
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1643-1654
Published Date: 10 July 2020
Easy to Perform Physical Performance Tests to Identify COPD Patients with Low Physical Activity in Clinical Practice
Matkovic Z, Tudoric N, Cvetko D, Esquinas C, Rahelic D, Zarak M, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:921-929
Published Date: 24 April 2020
Association Between Routine Blood Biomarkers and Clinical Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease
Nuñez A, Marras V, Harlander M, Mekov E, Esquinas C, Turel M, Lestan D, Petkov R, Yanev N, Pirina P, Negri S, Miravitlles M, Barrecheguren M
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:681-690
Published Date: 31 March 2020
Time To Revise COPD Treatment Algorithm
Matsunaga K, Oishi K, Miravitlles M, Anzueto A
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2229-2234
Published Date: 27 September 2019
Comparison of clinical baseline characteristics between Asian and Western COPD patients in a prospective, international, multicenter study
Kim KY, Miravitlles M, Sliwinski P, Costello R, Carter V, Tan J, Lapperre TS, Alcazar B, Gouder C, Esquinas C, García-Rivero JL, Kemppinen A, Tee A, Roman-Rodríguez M, Soler-Cataluña JJ, Price D, Rhee CK
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1595-1601
Published Date: 25 July 2019
Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
Avdeev S, Aisanov Z, Arkhipov V, Belevskiy A, Leshchenko I, Ovcharenko S, Shmelev E, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1267-1280
Published Date: 10 June 2019
Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research – a consensus document from six scientific societies [Corrigendum]
Rossi A, Butorac-Petanjek B, Chilosi M, Cosío BG, Flezar M, Koulouris N, Marin J, Miculinic N, Polese G, Samaržija M, Skrgat S, Vassilakopoulos T, Vukić-Dugac A, Zakynthinos S, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:247-248
Published Date: 18 January 2019
Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East-North Africa region, 2017 [Corrigendum]
Mahboub BH, Vats MG, Al Zaabi A, Iqbal MN, Safwat T, Al-Hurish F, Miravitlles M, Singh D, Asad K, Zeineldine S, Al Hajjaj MS
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:115-116
Published Date: 18 January 2019
Russian guidelines for the management of COPD: algorithm of pharmacologic treatment [Corrigendum]
Aisanov Z, Avdeev S, Arkhipov V, Belevskiy A, Chuchalin A, Leshchenko I, Ovcharenko S, Shmelev E, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:243-244
Published Date: 18 January 2019
Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum]
Martinez-Garcia MA, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:245-246
Published Date: 18 January 2019
Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study [Corrigendum]
Casas A, Montes de Oca M, Menezes AMB, Wehrmeister FC, Lopez Varela MV, Mendoza L, Ramírez L, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:241-242
Published Date: 18 January 2019
Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire
Núñez A, Esquinas C, Barrecheguren M, Calle M, Casamor R, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3837-3844
Published Date: 26 November 2018
Validation of clinical control in COPD as a new tool for optimizing treatment
Soler-Cataluña JJ, Marzo M, Catalán P, Miralles C, Alcazar B, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3719-3731
Published Date: 14 November 2018
How whole-body vibration can help our COPD patients. Physiological changes at different vibration frequencies
Pleguezuelos E, Casarramona P, Guirao L, Samitier B, Ortega P, Vila X, Del Carmen A, Ovejero L, Moreno E, Serra N, Gomís M, Garnacho-Castaño MV, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3373-3380
Published Date: 18 October 2018
Prevalence of smoking in a psychiatric hospital and its relationship with respiratory symptoms and the prevalence of COPD
Lores L, Monje A, Bergada M, Arellano E, Rodríguez-Larrea J, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2797-2804
Published Date: 7 September 2018
Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study
Casas A, Montes de Oca M, Menezes AMB, Wehrmeister FC, Lopez Varela MV, Mendoza L, Ramírez L, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1545-1556
Published Date: 11 May 2018
Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study
Vogelmeier CF, Chapman KR, Miravitlles M, Roche N, Vestbo J, Thach C, Banerji D, Fogel R, Patalano F, Olsson P, Kostikas K, Wedzicha JA
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1125-1134
Published Date: 10 April 2018
Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT)
Esquinas C, Serreri S, Barrecheguren M, Rodríguez E, Nuñez A, Casas-Maldonado F, Blanco I, Pirina P, Lara B, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1001-1007
Published Date: 23 March 2018
Depressive status explains a significant amount of the variance in COPD assessment test (CAT) scores
Miravitlles M, Molina J, Quintano JA, Campuzano A, Pérez J, Roncero C
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:823-831
Published Date: 6 March 2018
Mixed Th2 and non-Th2 inflammatory pattern in the asthma–COPD overlap: a network approach
Pérez de Llano L, Cosío BG, Iglesias A, de las Cuevas N, Soler-Cataluña JJ, Izquierdo JL, López-Campos JL, Calero C, Plaza V, Miravitlles M, Torrego A, Martinez‐Moragon E, Soriano JB, Lopez Viña A, Bobolea I
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:591-601
Published Date: 12 February 2018
Russian guidelines for the management of COPD: algorithm of pharmacologic treatment
Aisanov Z, Avdeev S, Arkhipov V, Belevskiy A, Chuchalin A, Leshchenko I, Ovcharenko S, Shmelev E, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:183-187
Published Date: 8 January 2018
Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique
Blanco I, Diego I, Bueno P, Fernández E, Casas-Maldonado F, Esquinas C, Soriano JB, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:57-67
Published Date: 21 December 2017
Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency
Esquinas C, Janciauskiene S, Gonzalo R, Mas de Xaxars G, Olejnicka B, Belmonte I, Barrecheguren M, Rodríguez E, Nuñez A, Rodríguez-Frías F, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3381-3390
Published Date: 29 November 2017
Characteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian Federation: the SUPPORT trial
Arkhipov V, Arkhipova D, Miravitlles M, Lazarev A, Stukalina E
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3255-3262
Published Date: 3 November 2017
Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East–North Africa region, 2017
Mahboub BH, Vats MG, Al Zaabi A, Iqbal MN, Safwat T, Al-Hurish F, Miravitlles M, Singh D, Asad K, Zeineldine S, Al-Hajjaj MS
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2869-2890
Published Date: 9 October 2017
Impact and prevention of severe exacerbations of COPD: a review of the evidence
Halpin DMG, Miravitlles M, Metzdorf N, Celli B
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2891-2908
Published Date: 5 October 2017
Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research – a consensus document from six scientific societies
Rossi A, Butorac-Petanjek B, Chilosi M, Cosío BG, Flezar M, Koulouris N, Marin J, Miculinic N, Polese G, Samaržija M, Skrgat S, Vassilakopoulos T, Vukić-Dugac A, Zakynthinos S, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2593-2610
Published Date: 29 August 2017
Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study
Calle Rubio M, Casamor R, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2373-2383
Published Date: 9 August 2017
When is dual bronchodilation indicated in COPD?
Thomas M, Halpin DMG, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2291-2305
Published Date: 3 August 2017
Palliative care and prognosis in COPD: a systematic review with a validation cohort
Almagro P, Yun S, Sangil A, Rodríguez-Carballeira M, Marine M, Landete P, Soler-Cataluña JJ, Soriano JB, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1721-1729
Published Date: 9 June 2017
Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide
Blanco I, Bueno P, Diego I, Pérez-Holanda S, Lara B, Casas-Maldonado F, Esquinas C, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1683-1694
Published Date: 8 June 2017
Bronchiectasis in COPD patients: more than a comorbidity?
Martinez-Garcia MA, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1401-1411
Published Date: 11 May 2017
Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study
Voorham J, Vrijens B, van Boven JFM, Ryan D, Miravitlles M, Law LM, Price DB
Pragmatic and Observational Research 2017, 8:31-41
Published Date: 18 April 2017
Self-reported daily walking time in COPD: relationship with relevant clinical and functional characteristics
Ramon MA, Esquinas C, Barrecheguren M, Pleguezuelos E, Molina J, Quintano JA, Roman-Rodríguez M, Naberan K, Llor C, Roncero C, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1173-1181
Published Date: 13 April 2017
Characteristics of COPD patients initiating treatment with aclidinium or tiotropium in primary care in Catalonia: a population-based study
Monteagudo M, Roset M, Rodriguez-Blanco T, Muñoz L, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1145-1152
Published Date: 12 April 2017
Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update
Blanco I, Bueno P, Diego I, Pérez-Holanda S, Casas-Maldonado F, Esquinas C, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:561-569
Published Date: 13 February 2017
Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach
Belmonte I, Barrecheguren M, López-Martínez RM, Esquinas C, Rodríguez E, Miravitlles M, Rodríguez-Frias F
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2535-2541
Published Date: 11 October 2016
The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis
Miravitlles M, Chapman KR, Chuecos F, Ribera A, Garcia Gil E
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2041-2053
Published Date: 29 August 2016
Diagnosis of alpha-1 antitrypsin deficiency: a population-based study
Barrecheguren M, Monteagudo M, Simonet P, Llor C, Rodriguez E, Ferrer J, Esquinas C, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:999-1004
Published Date: 10 May 2016
POPE study: rationale and methodology of a study to phenotype patients with COPD in Central and Eastern Europe
Zbozinkova Z, Barczyk A, Tkacova R, Valipour A, Tudoric N, Zykov K, Somfay A, Miravitlles M, Koblizek V
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:611-622
Published Date: 22 March 2016
Cognitive status among patients with chronic obstructive pulmonary disease
Roncero C, Campuzano AI, Quintano JA, Molina J, Pérez J, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:543-551
Published Date: 16 March 2016
Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation
Santos S, Marin A, Serra-Batlles J, de la Rosa D, Solanes I, Pomares X, López-Sánchez M, Muñoz-Esquerre M, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:515-525
Published Date: 11 March 2016
A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD
Miravitlles M, Montero-Caballero J, Richard F, Santos S, Garcia-Rivero JL, Ortega F, Ribera X
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:407-415
Published Date: 26 February 2016
Cost-effectiveness of combination therapy umeclidinium/vilanterol versus tiotropium in symptomatic COPD Spanish patients
Miravitlles M, Gáldiz JB, Huerta A, Villacampa A, Carcedo D, Garcia-Rio F
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:123-132
Published Date: 18 January 2016
The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD
Miravitlles M, García-Sidro P, Fernández-Nistal A, Buendía MJ, Espinosa de los Monteros MJ, Esquinas C, Molina J
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2571-2579
Published Date: 30 November 2015
The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK
Brusselle G, Price D, Gruffydd-Jones K, Miravitlles M, Keininger DL, Stewart R, Baldwin M, Jones RC
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2207-2217
Published Date: 15 October 2015
Is a previous diagnosis of asthma a reliable criterion for asthma–COPD overlap syndrome in a patient with COPD?
Barrecheguren M, Román-Rodríguez M, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1745-1752
Published Date: 1 September 2015
What pulmonologists think about the asthma–COPD overlap syndrome
Miravitlles M, Alcázar B, Alvarez FJ, Bazús T, Calle M, Casanova C, Cisneros C, de-Torres JP, Entrenas LM, Esteban C, García-Sidro P, Cosio BG, Huerta A, Iriberri M, Izquierdo JL, López-Viña A, López-Campos JL, Martínez-Moragón E, Pérez de Llano L, Perpiñá M, Ros JA, Serrano J, Soler-Cataluña JJ, Torrego A, Urrutia I, Plaza V
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1321-1330
Published Date: 15 July 2015
Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD
Wilson R, Anzueto A, Miravitlles M, Arvis P, Haverstock D, Trajanovic M, Sethi S
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:985-993
Published Date: 2 June 2015
Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease
Miravitlles M, Price D, Rabe KF, Schmidt H, Metzdorf N, Celli B
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:549-564
Published Date: 16 March 2015
Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease
Miravitlles M, Huerta A, Valle M, García-Sidro P, Forné C, Crespo C, López-Campos JL
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:367-377
Published Date: 16 February 2015
Caregivers’ burden in patients with COPD
Miravitlles M, Peña-Longobardo LM, Oliva-Moreno J, Hidalgo-Vega Á
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:347-356
Published Date: 12 February 2015
The concept of control of COPD in clinical practice
Soler-Cataluña JJ, Alcázar-Navarrete B, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:1397-1405
Published Date: 12 December 2014
Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns
Price D, West D, Brusselle G, Gruffydd-Jones K, Jones R, Miravitlles M, Rossi A, Hutton C, Ashton VL, Stewart R, Bichel K
International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:889-905
Published Date: 27 August 2014
COPD management: role of symptom assessment in routine clinical practice
van der Molen T, Miravitlles M, Kocks JWH
International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:461-471
Published Date: 14 October 2013
Beyond FEV1 in COPD: a review of patient-reported outcomes and their measurement
Jones P, Miravitlles M, van der Molen T, Kulich K
International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:697-709
Published Date: 16 October 2012
A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology
Wilson R, Anzueto A, Miravitlles M, Arvis P, Faragó G, Haverstock D, Trajanovic M, Sethi S
International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:373-383
Published Date: 29 June 2011
Antibiotic treatment of exacerbations of COPD in general practice: long-term impact on healthrelated quality of life
Marc Miravitlles, Carles Llor, Jesús Molina, et al
International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:11-19
Published Date: 15 January 2010
Geographic differences in clinical characteristics and management of COPD: the EPOCA study
Marc Miravitlles, Cristina Murio, Gema Tirado-Conde, Gur Levy, Hana Muellerova, et al
International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:803-814
Published Date: 5 December 2008
Efficacy of amoxycillin versus amoxycillin/clavulanate in acute exacerbations of chronic pulmonary obstructive disease in primary care
Carl Llor, Silvia Hernández, Anna Ribas, Carmen Álvarez, Josep Maria Cots, et al
International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:45-53
Published Date: 15 October 2008